Edit Varkondi
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Real-world performance analysis of a universal computational reasoning model for precision oncology in lung cancer.
Journal: NPJ precision oncology
Published: November 28, 2024
Correction to: Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.
Journal: World journal of pediatrics : WJP
Published: May 29, 2023
Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.
Journal: World journal of pediatrics : WJP
Published: October 20, 2022
Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy.
Journal: JCO precision oncology
Published: January 10, 2022
Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support.
Journal: Diagnostics (Basel, Switzerland)
Published: September 07, 2021
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.
Journal: NPJ precision oncology
Published: September 24, 2020
Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC.
Journal: Journal of personalized medicine
Published: July 17, 2020
Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers.
Journal: PloS one
Published: May 08, 2017
Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 02, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026